| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492535A1 Anhydrous crystalline forms i and ii of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) |
| 01/05/2005 | CN1561341A Hydrolysis of [R(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 01/05/2005 | CN1561332A Preparation of HIV protease inhibitors |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183115C 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 01/05/2005 | CN1183114C Quinoline derivatives and quinazoline derivatives |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/04/2005 | US6838527 Polymer-immobilized α-iminoester |
| 01/04/2005 | US6838484 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266820 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
| 12/30/2004 | US20040266819 Using a 2-aminoquinoline compound |
| 12/30/2004 | US20040266818 Histone deacetylase inhibitors; antiproliferative agents; autoimmune, allergic and inflammatory diseases; central nervous system disorders; potency, bioavailability |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040262575 Rare earth metal compounds having at least one lanthanide metal and a 2-hydroxyquinoline-4-carboxylic acid |
| 12/29/2004 | WO2004113301A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 12/29/2004 | WO2004112710A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß |
| 12/29/2004 | WO2004078119A3 Substituted thiophenes with antibacterial activity |
| 12/29/2004 | WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/29/2004 | EP1491533A2 Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors |
| 12/29/2004 | EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1490362A2 (homo)piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
| 12/29/2004 | EP1490341A1 Novel adamantane derivatives |
| 12/29/2004 | EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490064A1 Substituted pyridinones as modulators of p38 map kinase |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
| 12/29/2004 | CN1182116C Mutilin derivatives and their use as antibacterials |
| 12/29/2004 | CN1182112C Process for the production of a N-benzyl azetidine-2-carboxylic acid ester |
| 12/29/2004 | CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient |
| 12/28/2004 | US6835838 Condensation of silicon compounds with aldehydes in the presence of titanium catalysts in solvents, then reducing and hydolyzing to form drugs used for prophylaxis of atherosclerosis or as enzyme inhibitors |
| 12/28/2004 | US6835836 Dichlorinated heterocyclic compounds and methods of synthesis |
| 12/28/2004 | US6835737 Quinoline inhibitors of cGMP phosphodiesterase |
| 12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
| 12/28/2004 | US6835469 Phosphorescent compounds and devices comprising the same |
| 12/28/2004 | CA2126072C Tri-substituted phenyl derivatives and processes for their preparation |
| 12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 12/23/2004 | WO2004111008A2 Use of a compound of formula i for making a pharmaceutical composition |
| 12/23/2004 | WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110983A2 New benzamides as pparϒ modulators |
| 12/23/2004 | WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/23/2004 | US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259911 Quinoline derivatives process of synthesis and medicaments containing these derivatives |
| 12/23/2004 | US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 12/23/2004 | US20040259877 Inhibitors against the production and release of inflammatory cytokines |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/23/2004 | CA2528231A1 New benzamides as ppar.gamma. modulators |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/22/2004 | EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 12/22/2004 | EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| 12/22/2004 | EP1487795A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 12/22/2004 | CN1181059C Quinoline-4-base derivative I |
| 12/21/2004 | US6833455 Coloring plastics |
| 12/21/2004 | CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 12/16/2004 | WO2004108680A1 Intermediates and process for thr production of optically active quinolonecarboxylic acid derivatives |
| 12/16/2004 | WO2004108679A1 An improved method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
| 12/16/2004 | WO2004108678A1 (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity |
| 12/16/2004 | WO2004108663A1 N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/16/2004 | WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions |
| 12/16/2004 | WO2004069145A3 Anticancer compounds, process for their preparation and pharmaceutical compositions containing them |
| 12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/16/2004 | US20040254182 Enhanced propertied pharmaceuticals |
| 12/16/2004 | US20040254166 Substituted phenyl acetamides and their use as protease inhibitors |
| 12/16/2004 | US20040253205 c-Kit kinase inhibitor |
| 12/16/2004 | CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/15/2004 | EP1486488A1 Use of a compound of formula I for making a pharmaceutical composition |
| 12/15/2004 | EP1486486A2 Substituted B-thiocarboxylic acids |
| 12/15/2004 | EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS |
| 12/15/2004 | EP1485097A1 Crystalline forms of gatifloxacin and processes for preparation |
| 12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 12/15/2004 | EP1117639B1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
| 12/15/2004 | CN1555361A Butyric acid derivatives |
| 12/15/2004 | CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
| 12/15/2004 | CN1180050C Metal ligand compound, luminous device and display device |
| 12/15/2004 | CN1179947C Preparation method of organic electro luminescent material 8-hydroxy quinoline aluminium |
| 12/15/2004 | CN1179946C Process for preparing quinolylacrylonitrile and intermediates therefor |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
| 12/09/2004 | WO2004106322A2 Polymorphs of aripiprazole |
| 12/09/2004 | WO2004106305A1 New p2x7 receptor antagonists and their use |
| 12/09/2004 | WO2004072041A8 Tetrahydroquinolines as agonists of liver- x receptors |
| 12/09/2004 | US20040249154 Process for the manufacture of organic compounds |
| 12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
| 12/09/2004 | US20040248922 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 12/09/2004 | US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions |
| 12/09/2004 | US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine |
| 12/09/2004 | US20040248872 Safe for agricultural or gardening use; effective against insects and mammals |